Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine for Breast Lumpectomy
NCT02675049Phase 2Completed
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Start
- Jan 2016
- Primary completion
- Feb 2016
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of dexmedetomidine in breast cancer, sponsored by Tianjin Medical University Cancer Institute and Hospital. Started Jan 2016; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02675049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02675049.